Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Hiroyuki Ohbayashi, Yasuo Sato, Mari Kiuchi, Atsushi Nagazumi, Takumi Kanzo & Takazumi Kimura. (2022) Analysis of the impact on efficacy of lubiprostone dose reduction to manage adverse events in the treatment of chronic constipation in Japan. Expert Review of Gastroenterology & Hepatology 16:8, pages 809-817.
Read now
Read now
Amanda Almeida Gomes Dantas, Alianny Raphaely Rodrigues Pereira, Shamyr Sulyvan de Castro, Thaissa Hamana de Macedo Dantas, Caroline Wanderley Souto Ferreira, Isabelle Ribeiro Barbosa, Saionara Maria Aires da Câmara & Diego de Sousa Dantas. (2020) Is Constipation Associated with Worse Functioning in Adult Women? A Cross-Sectional Study. Journal of Multidisciplinary Healthcare 13, pages 883-889.
Read now
Read now
Arpita Nag, Susan A Martin, Deirdre Mladsi, Oyebimpe Olayinka-Amao, Molly Purser & Renu M Vekaria. (2020) The Humanistic and Economic Burden of Chronic Idiopathic Constipation in the USA: A Systematic Literature Review. Clinical and Experimental Gastroenterology 13, pages 255-265.
Read now
Read now
Douglas C. A. Taylor, Jessica L. Abel, Carolyn Martin, Jalpa A. Doshi, Breanna Essoi, Stephanie Korrer, David S. Reasner, Robyn T. Carson & Alyssa Goolsby Hunter. (2020) Comprehensive assessment of patients with irritable bowel syndrome with constipation and chronic idiopathic constipation using deterministically linked administrative claims and patient-reported data: the Chronic Constipation and IBS-C Treatment and Outcomes Real-World Research Platform (CONTOR). Journal of Medical Economics 23:10, pages 1072-1083.
Read now
Read now
Maham Hayat, Hassaan Zia & Salman Nusrat. (2019) Lubiprostone in the treatment of chronic idiopathic constipation: an update on health-related quality of life and patient-reported outcomes. Patient Related Outcome Measures 10, pages 43-47.
Read now
Read now
Philip B. Miner$suffix/text()$suffix/text(). (2018) Elobixibat, the first-in-class Ileal Bile Acid Transporter inhibitor, for the treatment of Chronic Idiopathic Constipation. Expert Opinion on Pharmacotherapy 19:12, pages 1381-1388.
Read now
Read now
Charles F. Barish & Patrick Griffin. (2018) Safety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label study. Current Medical Research and Opinion 34:4, pages 751-755.
Read now
Read now
Articles from other publishers (11)
Jeff LiangChristopher V. Almario, William D. CheyCarolyn S. HigginsBrennan M.R. Spiegel. (2023) Prevalence and Burden of Illness of Rome IV Chronic Idiopathic Constipation, Opioid-Induced Constipation, and Opioid-Exacerbated Constipation in the United States. American Journal of Gastroenterology 118:11, pages 2033-2040.
Crossref
Crossref
Lin ChangWilliam D. CheyAamer ImdadChristopher V. AlmarioAdil E. BharuchaSusan DiemKatarina B. GreerBrian HansonLucinda A. HarrisCynthia KoM. Hassan MuradAmit PatelEric D. ShahAnthony J. LemboShahnaz Sultan. (2023) American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. American Journal of Gastroenterology 118:6, pages 936-954.
Crossref
Crossref
Lucinda A. HarrisChristopher H. Chang. (2022) Burden of Constipation: Looking Beyond Bowel Movements. American Journal of Gastroenterology 117:4S, pages S2-S5.
Crossref
Crossref
Klaus Bielefeldt. (2022) Cost of Constipation. Journal of Clinical Gastroenterology 56:3, pages 249-256.
Crossref
Crossref
Eric D. Shah, Kyle StallerJudy NeeNitin K. AhujaWalter W. ChanAnthony LemboDarren M. BrennerCorey A. SiegelWilliam D. Chey. (2021) Evaluating the Impact of Cost on the Treatment Algorithm for Chronic Idiopathic Constipation: Cost-Effectiveness Analysis. American Journal of Gastroenterology 116:10, pages 2118-2127.
Crossref
Crossref
Bo Zhang, Mingdong Huo, Zhicheng Chen, Feng Gao, Yan Liu & Xingxin Zhou. (2021) Long-Term Administration of Anthraquinone Rhein on Induction of Constipation in Sprague-Dawley Rats via SCF/c-Kit Signaling Pathways. Canadian Journal of Gastroenterology and Hepatology 2021, pages 1-9.
Crossref
Crossref
Klaus Bielefeldt. (2020) Perceived Barriers to Treatment in Persons Treated for Functional Gastrointestinal Disease with Constipation. Digestive Diseases and Sciences 66:3, pages 739-750.
Crossref
Crossref
Sun Jung OhGarth FullerDevin PatelCarine KhalilWilliam SpaldingArpita NagBrennan M. R. SpiegelChristopher V. Almario. (2020) Chronic Constipation in the United States: Results From a Population-Based Survey Assessing Healthcare Seeking and Use of Pharmacotherapy. American Journal of Gastroenterology 115:6, pages 895-905.
Crossref
Crossref
Philip B. MinerJr.Jr.. (2019) Benefit–Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic Constipation. Drug Safety 42:5, pages 603-615.
Crossref
Crossref
Blanca Serrano-Falcón, Sílvia Delgado-Aros, Fermín Mearin, Constanza Ciriza de los Ríos, Jordi Serra, Miguel Mínguez, Miguel Montoro Huguet, Antonia Perelló, Cecilio Santander, Ángeles Pérez Aisa, Inmaculada Bañón-Rodríguez & Enrique Rey. (2019) Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms. Therapeutic Advances in Gastroenterology 12, pages 175628481985735.
Crossref
Crossref
Shin Fukudo, Hiroto Miwa, Atsushi Nakajima, Ken Haruma, Masanori Kosako, Ayako Nakagawa, Hiraku Akiho, Yusuke Yamaguchi, Jeffrey M. Johnston, Mark Currie & Yoshikazu Kinoshita. (2018) A randomized controlled and long-term linaclotide study of irritable bowel syndrome with constipation patients in Japan. Neurogastroenterology & Motility 30:12, pages e13444.
Crossref
Crossref